InvestorsHub Logo
Followers 0
Posts 50
Boards Moderated 0
Alias Born 10/15/2011

Re: The_Q post# 20238

Friday, 04/19/2019 10:14:31 AM

Friday, April 19, 2019 10:14:31 AM

Post# of 43722
Wow, I didn't realize that the dosage regimen in phase 3, was so much increased in frequency, and length of time!

This is a HUGE deal!!


I have another thought here, based on this "new to me" info.

Perhaps Geert's long-term plan, is to make Multikine THE Standard of Care! (whereby, the current SOC is only used IF Multikine fails to cause any measurable response, after 3-weeks)

That is, he is gradually "inching" towards "Multikine SOC", within the current boundaries of accepted SOC, and treatment ethics.

Argument being: If 10 days at whatever dosage did "X%" complete tumor disappearance, and 3-weeks in phase 3 did "X%+Y%", let's do a study where we give Multikine for 5-7 weeks (or longer)!

Imagine if the data suggested that could cause say, a 25% complete cure rate? And, all the while, showing that delaying current SOC beyond the current 3-weeks (for those having complete tumor disappearance, or shrinkage responses), would NOT be unethical?

Or, maybe I am just daydreaming..
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News